Overview A Shenzhen copper foil manufacturer has become the test case for whether US investors still have appetite for Chinese listings. According to Reuters, Londian Wason New Energy Tech set terms fOverview A Shenzhen copper foil manufacturer has become the test case for whether US investors still have appetite for Chinese listings. According to Reuters, Londian Wason New Energy Tech set terms f

Londian Wason IPO Date and Price Range Explained for FOIL Stock Investors

Overview

 
A Shenzhen copper foil manufacturer has become the test case for whether US investors still have appetite for Chinese listings. According to Reuters, Londian Wason New Energy Tech set terms for its initial public offering on August 3, targeting a valuation of up to $1.7 billion in what could be the largest New York listing by a Chinese company in more than a year.
 
 
The attention is not really about the company's size. Chinese listings in New York have dried up over the past year as geopolitical tensions escalated, while Beijing has encouraged domestic champions to list closer to home and sharpened scrutiny of firms pursuing offshore offerings. Against that backdrop, a modestly sized deal carries signalling weight out of proportion to its dollar value. Reuters cited IPOX Research noting that the offering is relatively small compared with the larger Chinese deals of previous years, which means a successful debut would be encouraging rather than a definitive reopening of the market.
 
For anyone considering participation, the practical questions come first: what the ticker is, which exchange, when pricing happens, when ordinary investors can trade, and what the valuation implies given the current financials.
 

Key Takeaways

 
The ticker is FOIL and the listing venue is the New York Stock Exchange. The stock is not yet trading.
 
The company is offering 3,571,429 American Depositary Shares, each representing five ordinary shares with a par value of $0.00001, equivalent to 17,857,145 ordinary shares in total.
 
The price range is $20.00 to $22.00 per ADS. At the $21.00 midpoint the deal raises roughly $75 million, at the top of the range roughly $78.6 million, and up to roughly $90.4 million if the over-allotment is exercised in full.
 
Underwriters may purchase up to an additional 535,714 ADSs within 30 days to cover over-allotments.
 
At the $21.00 midpoint the implied market capitalisation is about $1.63 billion, rising to as much as $1.7 billion at the top of the range.
 
Renaissance Capital indicates the deal is expected to price during the week of August 10, 2026. The company has not issued a formal announcement confirming a specific date.
 
Harvest Global Capital Investments, Hithium Global and other investors have indicated interest in up to $50 million, $7 million and $30 million of ADSs respectively.
 

Inside the Business Behind the Ticker

 

Products and Market Position

 
Londian Wason is a Cayman Islands holding company operating primarily through subsidiaries in China. Its Form F-1 registration statement filed with the US Securities and Exchange Commission describes a business that researches, develops and manufactures electrolytic copper foil, including lithium-ion battery foil used in electric vehicles and energy storage systems, and PCB-grade foil for high-performance electronics. Citing Frost & Sullivan, the filing states the company was the world's largest supplier of LiB copper foil by sales volume in 2025, with a 7.6% share.
 
Founded in 2001, the company operates six manufacturing sites in China with roughly 180,500 metric tons of annual designed capacity, and held 634 patents in China as of December 31, 2025. Its product line extends to ultra-thin, high-strength foils down to 4 microns, plus HVLP and RTF products aimed at next-generation communications and AI applications. Renaissance Capital's deal note adds that a further production base is under construction in Malaysia.
 
The customer roster is the most immediately persuasive part of the equity story. The filing names LG Energy Solution, Panasonic, SK On, Samsung SDI, ATL, CATL and BYD, covering most of the world's leading cell manufacturers.
 

Backers and Leadership

 
Reuters reported that the company's major backers include South Korea's SK Group and Mirae Asset, and that it is led by co-CEOs Guanran Wang and Guangling Zhou. Beijing approved the planned New York IPO in December, making it one of the few US listing applications cleared by the China Securities Regulatory Commission over the past year.
 
That approval matters more than it might appear. It means the principal regulatory uncertainty has already been resolved, leaving the remaining variables concentrated on the demand side.
 

Breaking Down the Offering Terms

 

Ticker, Venue and ADS Structure

 
According to Investing.com's report on the filing, the company intends to list on the NYSE under the symbol FOIL, offering 3,571,429 ADSs with each ADS representing five ordinary shares. That ratio is essential for any valuation work: an ADS price reflects the economic interest in five ordinary shares and cannot be compared directly with an ordinary share price.
 
Investors should also note the corporate structure. Purchasers acquire equity securities of a Cayman Islands holding company rather than direct equity in the operating subsidiaries in China. The registration statement flags this explicitly, and it is a characteristic shared across similarly structured China-based listings.
 

Price, Proceeds and Valuation

 
The range is $20.00 to $22.00 per ADS. IPOScoop's deal note states that pricing at the $21.00 midpoint would raise $75 million and imply a market capitalisation of $1.63 billion. Reuters calculated from the top of the range, giving proceeds of up to $78.6 million and a valuation of up to $1.7 billion, with total proceeds reaching as much as $90.4 million if the over-allotment option is exercised.
 
Cantor and Huatai Securities lead the underwriting syndicate, which also includes CMB International, US Tiger Securities, Fortune (HK) Securities and VC Brokerage.
 
One detail deserves attention. Renaissance Capital's July 2 filing note carried an estimated deal size of $350 million, well above the $75 million eventually announced. That earlier figure was a third-party estimate made before terms were set rather than a company target, so it should not be read directly as a downsizing. The gap nonetheless says something about the pricing environment.
 

Timing

 
Renaissance Capital indicates the deal is expected to price during the week of August 10, 2026. US IPOs are conventionally priced after the close and begin trading the following morning, but the company has not published a formal announcement fixing either the pricing date or the first trading day. Until that announcement appears, any specific calendar date should be treated as expectation rather than confirmation.
 
 
A note on that. Some venues list derivative contracts referencing a stock before the underlying shares begin trading, including the related contract on MEXC. These instruments price market expectations about where the deal will settle. Holding a contract is not the same as holding equity, confers no shareholder rights, and adds leverage and funding cost risk on top of the underlying volatility. The risk profile differs fundamentally from subscribing to or buying the shares themselves.
 

What the Financials Actually Show

 

Large Revenue, Very Thin Margins

 
This is the single most important dataset for assessing the valuation. IPOScoop, citing the prospectus, reported net income of $2.9 million on revenue of $1.6 billion for the twelve months ended December 31, 2025. That is a net margin of roughly 0.2%.
 
The first quarter of 2026 looked materially different. Reuters reported net profit of RMB 134.5 million, about $19.2 million, on revenue of RMB 4.07 billion for the three months ended March 31, against a net loss of RMB 68.4 million on revenue of RMB 1.91 billion a year earlier. Revenue more than doubled year on year and the company swung from loss to profit.
 

How to Frame the Valuation

 
Measuring a $1.63 billion market capitalisation against $2.9 million of full-year 2025 net income produces a multiple with no analytical content. Annualising the first quarter's $19.2 million to roughly $77 million instead implies a rough multiple near 21 times. The distance between those two figures is the point: what the market has to underwrite is not historical earnings but whether the first-quarter margin is durable.
 
An industry characteristic belongs in that assessment. Copper foil is typically priced as the underlying copper cost plus a processing fee, so a rising copper price lifts both revenue and cost, and headline revenue growth is not necessarily the same as growth in processing fee income. The relevant disclosures are the segment and gross margin tables in the prospectus rather than the top-line comparison.
 

Why a Modest Deal Is Drawing Outsized Attention

 

Testing the Window for Chinese Listings

 
Reuters set out the logic plainly. Chinese listings in New York have dried up over the past year amid escalating geopolitical tension between the two largest economies, while Beijing has pushed domestic champions toward closer-to-home venues and tightened scrutiny of offshore offerings. In that environment, a deal that has cleared CSRC review, carries a mainstream syndicate and has visible institutional indications functions as a sample.
 
IPOX Research provided the restrained benchmark: the offering is small relative to earlier Chinese deals, so a strong debut would be encouraging without amounting to proof that the market has reopened.
 

Indications Exceed the Deal Size

 
On the disclosed figures, Harvest Global Capital Investments at up to $50 million, Hithium Global at up to $7 million and other investors at up to $30 million total roughly $87 million, above the $75 million midpoint raise.
 
The nature of those figures should be read precisely. The prospectus language describes indications of interest rather than binding commitments, and final allocation is determined at pricing. From a deal-risk perspective, however, indication coverage above the deal size generally reduces the probability of a failed offering.
 

Risks and Scenarios

 

The Float Is the Dominant Variable

 
Working backwards from the $21.00 midpoint and the $1.63 billion valuation implies roughly 77.6 million ADS-equivalent units outstanding, against which the 3,571,429 ADSs on offer represent about 4.6%, or roughly 5.3% with the over-allotment fully exercised. This is a calculation derived from published figures, and the definitive numbers should be taken from the final prospectus.
 
A float that small means two things simultaneously. Early price swings can be amplified considerably, and price discovery is correspondingly less reliable. Sharp early volatility in small-float China-based listings has been common historically, and it is a separate question from the quality of the underlying business.
 

The Calendar Can Move

 
US IPOs can be postponed, downsized or withdrawn before pricing, typically because of market conditions, weak bookbuilding feedback or unresolved process items. No formal pricing announcement has been issued, and the widely cited week of August 10 comes from third-party scheduling information. Meaningful macro volatility inside the pricing window could readily shift the timetable.
 

Three Paths

 
The base case is pricing within the range and a normal debut, with elevated first-day volatility but a completed transaction that establishes a reference valuation for subsequent Chinese offerings.
 
A second path is pricing above the range. Strong institutional demand could push the valuation beyond $1.7 billion, strengthening the signal for the broader pipeline while raising the post-listing bar the company must grow into.
 
A third is delay or downsizing. Weaker market conditions could push the deal into a later window. That alone would say nothing about the business, but it would weaken the reopening narrative.
 

Exclusive View from James Mitchell

 
What makes this deal worth studying is not the valuation level but the two structural facts it exposes at once. The regulatory channel for Chinese issuers to reach New York clearly still functions, and the size of the capital the market is willing to price through that channel has shrunk considerably. CSRC clearance arrived in December, the syndicate is complete, indications cover the raise. The process works. Yet $75 million of proceeds against a valuation in the $1.6 billion range means the company is parting with under 5% of its equity. That is a listing-first, funding-later structure, and its primary purpose looks closer to establishing a public market reference price than to solving a capital requirement.
 
Two misreadings look likely. The first is extrapolating the first-quarter margin improvement in a straight line. Going from $2.9 million of full-year net income to $19.2 million in a single quarter is too large a jump to establish a trend from one data point, and under a copper-plus-processing-fee pricing model the relationship between revenue growth and earnings quality needs unpacking before it can be relied on. The second is treating the tiny float as a scarcity premium. Low float does amplify upside, but it amplifies drawdowns identically, and the supply picture changes as lock-ups roll off. Reading early price action as a valuation signal is the standard error in transactions shaped like this one.
 
Three variables deserve tracking from here. Where the deal actually prices within, above or below the range is the most direct read on institutional demand. The rate at which volume decays between the second and fourth weeks after listing is where the real liquidity of a small-float name reveals itself. And the processing fee and segment gross margin disclosures in the prospectus will determine whether the first-quarter improvement came from pricing power or from the copper cycle.
 
For cross-asset investors, the transferable lesson concerns how much supply structure drives price. Whether the constraint is a listed equity's free float or a digital asset's initial circulating supply, the early price formation logic is the same: when tradeable supply is far smaller than latent demand, price reflects the scarcity condition more than any valuation judgement, and as supply releases over time the price level typically recalibrates. The same framework applies to stock-referencing derivative contracts, which before the underlying opens are pricing expectation rather than fundamentals, and whose deviation from the eventual opening print is itself a quantifiable sentiment reading. From a risk management standpoint, sizing positions conservatively while liquidity is still unsettled matters more than getting the direction right.
 
This analysis rests on the registration statement, company disclosures and credible reporting available now. The pricing outcome, final allocation and subsequent operating results could each change the conclusion, and no single scenario should be treated as a fixed expectation.
 

FAQ

 

What does Londian Wason do?

 
Londian Wason New Energy Tech is a Cayman Islands holding company headquartered in Shenzhen, founded in 2001, operating through subsidiaries in China. It manufactures electrolytic copper foil, including lithium-ion battery foil for electric vehicles and energy storage plus PCB-grade foil for electronics. Its SEC registration statement, citing Frost & Sullivan, states it was the world's largest LiB copper foil supplier by sales volume in 2025 with a 7.6% share, serving customers including CATL, BYD, LG Energy Solution, Samsung SDI and Panasonic.
 

What is the FOIL ticker and which exchange is it listing on?

 
The ticker is FOIL and the venue is the New York Stock Exchange, not Nasdaq. Until trading begins this remains a proposed symbol. Both the public filing and Reuters confirm the NYSE listing under that symbol. Anyone encountering a venue claiming to offer the underlying shares before the listing completes should verify carefully what is actually being traded.
 

How many ordinary shares does each ADS represent?

 
Each American Depositary Share represents five ordinary shares with a par value of $0.00001 per share. The offering of 3,571,429 ADSs therefore corresponds to 17,857,145 ordinary shares. The ratio matters for valuation work: an ADS quote reflects the interest in five ordinary shares, so it cannot be compared directly with an ordinary share price or with peer share prices quoted on other markets.
 

What is the price range and how much is being raised?

 
The range is $20.00 to $22.00 per ADS. At the $21.00 midpoint the raise is roughly $75 million, and at the top of the range roughly $78.6 million. Underwriters may buy up to an additional 535,714 ADSs within 30 days to cover over-allotments, which would take total proceeds to as much as $90.4 million. Final pricing can land inside, above or below the range, and the pricing announcement is the authoritative source.
 

What valuation is Londian Wason targeting?

 
Pricing at the $21.00 midpoint implies a market capitalisation of roughly $1.63 billion. Reuters calculated up to $1.7 billion using the top of the range. For context, the company reported net income of $2.9 million on revenue of $1.6 billion for the twelve months ended December 31, 2025, and net profit of RMB 134.5 million, about $19.2 million, in the first quarter of 2026. The gap between historical earnings and the implied valuation is what the market has to assess.
 

When will FOIL price and when does trading start?

 
Renaissance Capital indicates the deal is expected to price during the week of August 10, 2026. US IPOs conventionally price after the close with trading beginning the next morning. The company has not formally announced either date, so all specific dates remain expectations at this stage. Ordinary investors can buy or sell FOIL in the secondary market only once the shares actually begin trading on the NYSE.
 

Is the company already public?

 
No. FOIL remains in the offering stage and there is no public trading market for the shares. The prospectus states explicitly that prior to this offering no public market existed for the ADSs or the ordinary shares. Derivative contracts referencing the stock that some venues list price expectations about the outcome; holding such a contract is not equity ownership and carries no shareholder rights.
 

Could the offering be delayed?

 
Yes. US IPOs can be postponed, resized or pulled before pricing because of market conditions, disappointing bookbuilding feedback or procedural factors. No formal pricing announcement has been published, and the commonly cited window comes from third-party scheduling data. The China Securities Regulatory Commission approved the New York listing in December, so the principal regulatory hurdle has been cleared and the remaining uncertainty sits with market demand.
 

Disclaimer

 
This article is provided for informational and research purposes only and does not constitute investment advice, financial advice, legal advice, tax advice or any recommendation to transact. The offering terms, financial data and timing referenced here are drawn from public filings and credible reporting; the company's formal announcements and final prospectus are the authoritative sources, and some details had not been confirmed by the company at the time of publication. Prices of crypto assets, equities and other related financial instruments can move sharply over short periods, and newly listed securities are especially prone to severe volatility in early trading, with the possibility of total loss of principal. Derivative contracts referencing a stock carry leverage risk, do not represent ownership of the underlying company, and have a fundamentally different risk profile from holding shares directly. Historical performance, technical indicators and on-chain data cannot guarantee future outcomes and should not be read as a promise or forecast regarding any asset. Readers should conduct their own independent research, verify official information directly, and evaluate any decision against their own financial circumstances, investment objectives, experience and risk tolerance, consulting a qualified professional adviser where appropriate. The MEXC Crypto Pulse team accepts no liability for any direct or indirect loss arising from use of or reliance on the information in this article.
 

About the Author

 
James Mitchell specializes in technical analysis, market trends, and trading strategies for both Bitcoin and altcoins. Based in London, he has over 10 years of experience in financial markets. Before joining MEXC Learn, James worked as a senior analyst at a leading European investment firm, where he developed expertise in risk management and quantitative trading. His transition to cryptocurrency markets began in 2017, and he has since become recognized for his data-driven approach. He holds a Master's degree in Financial Economics from the London School of Economics. His analytical approach combines traditional technical analysis with on-chain metrics to provide readers with actionable insights.
 
Areas of Expertise:
  • Technical Analysis
  • Market Trends & Cycles
  • Trading Strategies
  • Bitcoin & Altcoin Analysis
  • Risk Management
     

Research References

 
 
Want the fastest access to MEXC's latest updates? Join our official Telegram group now!
Join MEXC Community: X (Twitter) | Telegram | Discord
Account Verification: Understand KYC | How to Complete KYC
External Content Platforms: Substack | Medium | Paragraph | LinkedIn | X(News)
Market Opportunity
Movement Logo
Movement Price(MOVE)
--
----
USD
Movement (MOVE) Live Price Chart

Description:Crypto Pulse is powered by AI and public sources to bring you the hottest token trends instantly. For expert insights and in-depth analysis, visit MEXC Learn.

The articles shared on this page are sourced from public platforms and are provided for reference only. They do not represent the position or views of MEXC. All rights belong to James Mitchell. If you believe any content infringes upon the rights of a third party, please contact service@support.mexc.com for prompt removal. MEXC does not guarantee the accuracy, completeness, or timeliness of any content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be interpreted as a recommendation or endorsement by MEXC. For expert insights and in-depth analysis, visit MEXC Learn.